Clinical trial
Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Refractory Angina Pectoris
NCT00776568 is registered in ClinicalTrials.gov with Universal Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Refractory Angina Pectoris
- Lead sponsor
- Universal Research Group
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- February 29, 2008
- Completion date
- Not reported
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.